Most of the drugs sold in the U.S. come from overseas, exposing those supply chains to disruptions like natural disasters or political conflicts. Some researchers argue that using 3D printing to make drugs at the site of care could increase resiliency.
Matt Blois talks to one of those researchers on this episode of Medically Necessary, welcoming Sheng Qi from the University of East Anglia in Norwich, England. The two discuss using 3D printers to produce personalized drugs for patients.
When it comes to drugs, the promise of 3D printing is personalization. Health care providers could provide a dose that precisely matches a patient’s needs. The hope is that a more precise dose would reduce side effects and increase benefits. It’s also possible to do things like combining multiple medications into a single pill to make it easier for patients to adhere to complex medication regimens.
You can find more Medically Necessary episodes and recaps for all our live podcasts here.